Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

RDY - Dr. Reddy`s Laboratories Ltd. - ADR

Close
83.47
1.200   1.438%

Share volume: 170,819
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$82.27
1.20
1.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
47%
Profitability 46%
Dept financing 16%
Liquidity 53%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.59%
1 Month
3.52%
3 Months
20.18%
6 Months
8.91%
1 Year
22.11%
2 Year
62.61%
Key data
Stock price
$83.47
P/E Ratio 
0.00
DAY RANGE
$82.96 - $83.56
EPS 
$0.00
52 WEEK RANGE
$63.35 - $84.46
52 WEEK CHANGE
$0.23
MARKET CAP 
13.933 B
YIELD 
0.57%
SHARES OUTSTANDING 
166.923 M
DIVIDEND
$0.4792
EX-DIVIDEND DATE
07/30/2024
NEXT EARNINGS DATE
10/24/2024
BETA 
0.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$149,931
AVERAGE 30 VOLUME 
$193,194
Company detail
CEO: G. Prasad
Region: US
Website: http://www.drreddys.com/
Employees: 24,795
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

They are an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.

Recent news